As of 2026-10-10, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (53.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.61 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -8959.1%.
The range of the Relative Valuation is (50.49) - (94.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 15.9x | 7.0x |
| Forward P/E multiples | 7.3x - 13.6x | 8.5x |
| Fair Price | (50.49) - (94.19) | (53.60) |
| Upside | -8444.7% - -15669.2% | -8959.1% |
| Date | P/E |
| 2026-10-08 | -0.09 |
| 2026-10-07 | -0.09 |
| 2026-10-06 | -0.09 |
| 2026-10-05 | -0.10 |
| 2026-10-02 | -0.12 |
| 2026-10-01 | -0.13 |
| 2026-09-30 | -0.18 |
| 2026-09-29 | -0.17 |
| 2026-09-28 | -0.23 |
| 2026-09-25 | -0.23 |
| 2026-09-24 | -0.25 |
| 2026-09-23 | -0.25 |
| 2026-09-22 | -0.26 |
| 2026-09-21 | -0.27 |
| 2026-09-18 | -0.27 |
| 2026-09-17 | -0.26 |
| 2026-09-16 | -0.25 |
| 2026-09-15 | -0.22 |
| 2026-09-14 | -0.23 |
| 2026-09-11 | -0.23 |
| 2026-09-10 | -0.23 |
| 2026-09-09 | -0.24 |
| 2026-09-08 | -0.25 |
| 2026-09-04 | -0.26 |
| 2026-09-03 | -0.26 |
| 2026-09-02 | -0.26 |
| 2026-09-01 | -0.27 |
| 2026-08-31 | -0.30 |
| 2026-08-28 | -0.27 |
| 2026-08-27 | -0.28 |
| 2026-08-26 | -0.28 |
| 2026-08-25 | -0.28 |
| 2026-08-24 | -0.27 |
| 2026-08-21 | -0.28 |
| 2026-08-20 | -0.26 |
| 2026-08-19 | -0.29 |
| 2026-08-18 | -0.28 |
| 2026-08-17 | -0.26 |
| 2026-08-14 | -0.29 |
| 2026-08-13 | -0.29 |
| 2026-08-12 | -0.29 |
| 2026-08-11 | -0.30 |
| 2026-08-10 | -0.28 |
| 2026-08-07 | -0.31 |
| 2026-08-06 | -0.28 |
| 2026-08-05 | -0.28 |
| 2026-08-04 | -0.28 |
| 2026-08-03 | -0.28 |
| 2026-07-31 | -0.28 |
| 2026-07-30 | -1.01 |